Calreticulin as a novel B-cell receptor antigen in chronic lymphocytic leukemia

• Elisa ten Hacken,
• Maria Gounari,
• Jaap Willem Back,
• Ekaterina Shimanovskaya,
• Lydia Scarfò,
• Ekaterina Kim,
• Jared Burks,
• Maurilio Ponzoni,
• Giuseppe Alvise Ramirez,
• William G. Wierda,
• Zeev Estrov,
• Michael J. Keating,
• Alessandra Ferrajoli,
• Kostas Stamatopoulos,
• Paolo Ghia,
• Jan A. Burger

Affiliations

Elisa ten Hacken

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Maria Gounari

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy;Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece

Jaap Willem Back

Pepscan, Lelystad, the Netherlands

Ekaterina Shimanovskaya

Pepscan, Lelystad, the Netherlands

Lydia Scarfò

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy

Ekaterina Kim

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Jared Burks

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Maurilio Ponzoni

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy

Giuseppe Alvise Ramirez

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy

William G. Wierda

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Zeev Estrov

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Michael J. Keating

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Alessandra Ferrajoli

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Kostas Stamatopoulos

Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece

Paolo Ghia

IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy

Jan A. Burger

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA